Characterization of neuropeptide Y receptors mediating contraction, potentiation and inhibition of relaxation

Blood Pressure

Volumn 5, Issue 3, 1996, Pages 164-169

  Nilsson, Torun ^a   You, Junping ^a   Sun, Xiangying ^b   Hedner, Thomas ^b   Edvinsson, Lars ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

BIBP3226; cerebral arteries; guinea pig; mesenteric arteries; neuropeptide Y; NPY13 36; peptide YY; pro34NPY

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y RECEPTOR AGONIST; RECEPTOR SUBTYPE;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; DRUG RECEPTOR BINDING; GUINEA PIG; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; VASOCONSTRICTION;

EID: 0029940421     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.3109/08037059609062125     Document Type: Article

References (26)

1. Fried G, Terenius L, Hökfelt T, Goldstein M. Evidence for differential localization of noradrenaline and neuropeptide Y (NPY) in neuronal storage vesicles isolated from rat vas deferens. J Neurosci 1985; 5: 450-5.
2. Edvinsson L, Håkanson R, Wahlestedt C, Uddman R. Effects of neuropeptide Y on the cardiovascular system. Trends Pharmacol Sci 1987; 8: 231-5.
3. Pernow J, Lundberg JM, Kaijser L. Vasoconstrictor effects in vivo and plasma disappearance rate of neuropeptide Y in man. Life Sci 1987; 40: 47-54.
4. 1 receptors. Am J Physiol 1996. In press.
5. Edvinsson L, Ekblad E, Håkanson R, Wahlestedt C. Neuropeptide Y potentiates the effect of various vasoconstrictor agents on rabbit blood vessels. Br J Pharmacol 1984; 83: 519-25.
6. Fallgren B, Ekblad E, Edvinsson L. Co-existence of neuropeptides and differential inhibition of vasodilator responses by neuropeptide Y in guinea pig uterine arteries. Neurosci Lett 1989; 100: 71-6.
7. Wahlestedt C, Reis DJ, Neuropeptide Y-related peptides and their receptors - are the receptors potential therapeutic drug targets? Annu Rev Pharmacol Toxicol 1993; 32: 309-52.
8. Herzog H, Baumgartner M, Vivero C, Selbie LA, Bernhard A, Shine J. Genomic organisation, localisation and allelic differences in the gene for the human neuropeptide Y Y1 receptor. J Biol Chem 1993; 268: 7703-7.
9. 1 type. J Bio Chem 1992; 267: 10935-8.
10. Wahlestedt C, Yanaihara N, Håkanson R. Evidence for different pre- and postjunctional receptors for neuropeptide Y and related peptides. Reg Pept 1986; 13: 307-18.
11. Rose PM, Fernandes P, Lynch JS, et al. Cloning and functional expression of a cDNA encoding a human type 2 Neuropeptide Y receptor. J Biol Chem 1995; 270: 22661-4.
12. 1 receptors for NPY and PYY on vascular smooth muscle cells in rat pancreas. Am J Physiol 1991; 260: G250-7.
13. Grundemar L, Mörner S, Högestätt E, Wahlestedt C, Håkanson R. Characterization of vascular neuropeptide Y receptors. Br Pharmacol 1992; 105: 45-50.
14. Modin A, Pernow J, Lundberg JM. Evidence for two neuropeptide Y receptors mediating vasoconstriction. Eur J Pharmacol 1991; 203: 165-71.
15. Edvinsson L, Erlinge D, Sun XY, Hedner T. Neuropeptide Y in sympathetic co-transmission: recent advances in the search for neuropeptide Y antagonists. Pharmacol Toxicol 1994; 74: 193-201.
16. 3 receptors. Eur J Pharmacol 1995; 278: R3-5.
17. 1 receptor antagonist: BIBP3226. Eur J Pharmacol 1994; 271: 11-13.
18. Fallgren B, Arlock P, Jansen I, Edvinsson L. Neuropeptide Y in cerebrovascular function: comparison of membrane potential changes and vasomotor responses evoked by NPY and other vasoconstrictors in guinea pig basilar arteries. Neurosci Lett 1990; 114: 117-22.
19. 1 receptor antagonist. Pharmacol Toxicol 1995; 76: suppl IV 76.
20. Wieland HA, Willim KD, Entzeroth M, et al. Subtype selectivity and antagonistic profile of the nonpeptide Y1 receptor antagonist BIBP3226. J Pharmacol Exp Ther 1995; 275: 143-9.
21. Doods HN, Wienen W, Entzeroth M, et al. Pharmacological characterization of the selective nonpeptide neuropeptid Y Y1 receptor antagonist BIBP3226. J Pharmacol Exp Ther 1995; 275: 136-42.
22. 1 antagonist BIBP3226. Br J Pharmacol 1995; 116: 2245-50.
23. 1 receptors mediating vasoconstriction in human cerebral arteries. Neurosci Lett 1996; 203: 1-4.
24. Adamsson M, Fallgren B, Edvinsson L. Inhibition of neuropeptide Y-induced potentiation of noradrenaline-induced vasoconstriction by PP56 (D-myo-inositol 1,2,6-tris-phosphate). Br J Pharmacol 1992; 105: 93-6.
25. Leblanc GG, Trimmer BA, Landis SC. Neuropeptide Y-like immunoreactivity in rat cranial parasympathetic neurons: coexistence with vasoactive intestinal peptide and choline acetyltransferase. Proc Natl Acad Sci USA 1987; 84: 3511-5.
26. Edvinsson L, Adamsson M. Neuropeptide Y inhibits relaxation of guinea pig cerebral, coronary, and uterine arteries: Blockade by D-myo-inositol-1,2,6-triphosfate. J Cardiovasc Pharmacol 1992; 20: 466-72.